Regulation of Human Breast Cancer by Secreted Growth Factors

References

• Lippman M. E, Bolan G. Oestrogen-responsive human breast cancer in long term tissue culture. Nature 1975; 256: 592–3
   PubMed Web of Science ®Google Scholar
• Dickson R. B, Huff K., Spencer E. M, Lippman ME. Induction of epidermal growth factor related polypeptides by 17 betaestradiol in MCF-7 human breast cancer cells. Endocrinology 1986; 118: 138–42
   PubMed Web of Science ®Google Scholar
• Shafie SM. Estrogen and the growth of breast cancer: new evidence suggests indirect action. Science 1980; 209: 701–2
   PubMedGoogle Scholar
• Dickson R. B, McManaway M. E, Lippman ME. Estrogen induced factors of breast cancer cells partially replace estrogen to promote tumor growth. Science 1986; 232: 1540–3
   PubMed Web of Science ®Google Scholar
• Downward J., Yarden Y., Mayes E., et al. Close similarity of epidermal growth factor receptor and v-erb-B oncogene protein sequences. Nature 1984; 307: 521–7
   PubMed Web of Science ®Google Scholar
• Nickell K. A, Halper J., Moses HL. Transforming growth factors in solid malignant neoplasms. Cancer Res 1983; 43: 1966–71
   PubMed Web of Science ®Google Scholar
• Bates S. E, McManaway M. E, Lippman M. E, Dickson RB. Characterization of estrogen responsive transforming activity in human breast carcinoma. Cancer Res 1986; 46: 1707–13
   PubMed Web of Science ®Google Scholar
• Bates S. E, Valverius E., Salomon D., Stampfer M., Lippman M. E, Dickson RB. Proc Annu Meet Am Assoc Cancer Res 1987; 28: 233
   Google Scholar
• Bates S. E, Davidson N. E, Valverius E. M, et al. Expression of transforming growth factor alpha and its messenger ribonucleic acid in human breast cancer: its regulation by estrogen and its possible functional significance. Mol Endocrinol 1988; 2: 543–55
   PubMed Web of Science ®Google Scholar
• Clarke R., Katz D., Glanz P., Valverius E., Dickson R. B, Kern F. Constitutive expression of transforming growth factor alpha is not sufficient to fully induce the hormone-independent phenotype in MCF-7 cells in vitro. Proc Annu Meet Endocrine Soc A 1988; 1235
   Google Scholar
• Blundell TL, Humbel RE. Hormone families: pancreatic hormones and homologous growth factors. Nature 1980; 287: 781–7
   PubMed Web of Science ®Google Scholar
• Zapf J., Froesch ER. Insulin like growth factors/somatomedins: structure, secretion, biological actions and physiological roles. Horm Res 1986; 24: 121–30
   PubMed Web of Science ®Google Scholar
• Ullrich A., Bell J. R, Chen E. Y, et al. Human insulin receptor and its relation to the tyrosine kinase family of oncogenes. Nature 1985; 313: 756–61
   PubMed Web of Science ®Google Scholar
• Morgan D. O, Edman J. C, Standring D. N, et al. Insulin like growth factor II receptor as a multifunctional binding protein. Nature 1987; 329: 301–7
   PubMed Web of Science ®Google Scholar
• Lobel P., Dahms N. M, Breitwmeyer J., Chirgwin J. M, Kornfeld S. Cloning of the bovine 215-kDa action-independent man-nose 6-phosphate receptor. Proc Natl Acad Sci (USA) 1987; 84: 2233–7
   PubMed Web of Science ®Google Scholar
• Wahed A., Braulke T., Junghans U., von Figura K. Mannose 6-phosphate/insulin-like growth factor II receptor: the two types of ligand bind simultaneously to one receptor at different sites. Biochem Biophys Res Comm 1988; 152: 1248–54
   PubMedGoogle Scholar
• Rochefort H., Capony F., Cavalie-Barthez G., et al. Estrogen-regulated proteins and autocrine control of cell growth in breast cancer. Dev Oncol 1986; 43: 57–68
   Google Scholar
• Cullen K. J, Yee D., Paik S., et al. Insulin-like growth factor II expression and activity in human breast cancer. Proc Annu Meet Am Assoc Cancer Res 1988; 29: 947
   Google Scholar
• Huff K. K, Kaufman D., Gabbay K. J, Spencer E. M, Lippman M. E, Dickson RB. Secretion of an insulin-like growth factor I related protein by human breast cancer cells. Canczr Res 1986; 46: 4613–9
   PubMed Web of Science ®Google Scholar
• Melton D. A, Krieg P. A, Rebagliati M. R, Maniatis T. Efficient in vitro synthesis of biologically active RNA and RNA hybridization probes from plasmids containing a bacteriophage SP6 promoter. Nucleic Acids Res 1984; 25: 7035–56
   Google Scholar
• Yee D., Favoni R. E, Huff K. K, et al. Insulin-like growth factor I expression and a novel IGF-I related activity in human malignancy. Proc Annu Meet Am Assoc Cancer Res 1988; 29: 216
   Google Scholar
• Kull F. C, Jacobs S., Su YF, Svoboda M. E, Van Wyk J. J, Cuatrecasas P. Monoclonal antibodies to receptors for insulin and somatomedin-C. J Biol Chem 1983; 258: 6561–6
   PubMed Web of Science ®Google Scholar
• Artega C. L, Kitten L., Coronado E., Jacobs S., Kull F., Osborne CK. Blockade of the type I somatomedin receptor inhibits growth of estrogen receptor negative human breast cancer cells in athymic mice. Proc Annu Meet Endo Soc 1988; 683
   Google Scholar
• Knabbe C., Lippman M. E, Wakefield L., et al. Evidence that TGF beta is a hormonally regulated negative growth factor in human breast cancer. Cell 1987; 48: 417–28
   PubMed Web of Science ®Google Scholar
• Sporn M. B, Roberts A. B, Wakefield L. S, Assoian RK. Transforming growth factor beta: biological function and chemical structure. Science 1986; 233: 532–4
   PubMed Web of Science ®Google Scholar
• Roberts A. B, Anzano M. A, Wakefield L. M, Roche N. S, Stern D. F, Sporn MB. Type beta transforming growth factor: a bifunctional regulator of cellular growth. Proc Natl Acad Sci (USA) 1985; 82: 119–23
   PubMed Web of Science ®Google Scholar
• Cheifetz S., Like B., Massague J. Cellular distribution of type I and type I1 receDtors for transforming growth factor beta. J Biol Chem 1986; 261: 9972–8
   PubMed Web of Science ®Google Scholar